ArticleJournal for immunotherapy of cancer2020

MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.

Victor H Engelhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.